Drug intelligence / Profile preview

Gynoclear

Development stage
Unknown
Lead developer
Metagenics
Administration
Oral
01

Overview

Gynoclear is a modified traditional Chinese herbal medicine (TCM) formulation developed by Metagenics (Aust) Pty Ltd for the management of endometriosis-related pain. Based on the classical Gui Zhi Fu Ling Wan (GZFLW) formula, Gynoclear is a multi-herb botanical product delivered in capsule form. It contains six active herbal ingredients: *Carthamus tinctorius* (Safflower), *Cinnamomum cassia* (Chinese cinnamon), *Poria cocos* (Hoelen), *Paeonia suffriticosa* (Tree peony), *Paeonia lactiflora* (Peony), and *Salvia miltiorrhiza* (Red sage). The formulation differs from the traditional GZFLW by the addition of *Salvia miltiorrhiza* (Dan Shen) and the substitution of *Semen persicae* (Tao Ren) with *Carthamus tinctorius* (Hong Hua). Gynoclear is currently being evaluated in clinical trials for its efficacy in reducing non-cyclical pelvic pain, dysmenorrhoea, and dyspareunia in women with endometriosis. Its therapeutic effects are attributed to broad anti-inflammatory activity and potential modulation of estrogen receptor pathways.

Brand names
Gynoclear
Other names
modified Gui Zhi Fu Ling Wan
02

Targets

ER (Estrogen receptor)

Beyond the preview

Go deeper on Gynoclear.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gynoclear.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call